Financial Performance - The company reported a revenue of RMB 300 million for the fiscal year 2023, representing a year-over-year growth of 15%[20]. - The company has set a revenue guidance of RMB 350 million for the fiscal year 2024, indicating a projected growth of 16.67%[20]. - The company's operating revenue for 2024 was ¥1,435,111,214.77, representing a 10.44% increase compared to ¥1,299,415,109.42 in 2023[25]. - The net profit attributable to shareholders for 2024 was -¥179,593,810.81, a significant decline of 1,311.61% from a profit of ¥14,822,793.00 in 2023[25]. - The company reported a basic earnings per share of -¥0.18 for 2024, a decrease of 1,900.00% from ¥0.01 in 2023[25]. - The company achieved a revenue of 1.435 billion yuan, representing a year-on-year growth of 10.44%[79]. - The semiconductor sector contributed ¥864,666,907.34, accounting for 60.25% of total revenue, with a year-on-year growth of 25.23%[85]. - The company reported a total of 1.57 billion yuan in committed investment projects, with 1.19 billion yuan already utilized[132]. Research and Development - In 2024, the company significantly increased its R&D investment, particularly in high-end photoresist products such as ArF and KrF, leading to a substantial rise in R&D expenses[4]. - The company is investing RMB 50 million in R&D for new product development, focusing on advanced semiconductor materials[20]. - R&D expenses reached ¥99,237,500, marking a 39.74% increase compared to the previous year, with R&D personnel growing by 20.69%[84]. - The company has developed a series of patented technologies for high-purity chemicals, including continuous production methods for high-purity nitric acid and hydrogen peroxide, which have been industrialized[69]. - The company has a total of 175 patents, including 74 invention patents, as of the end of the reporting period[180]. - The company is focused on enhancing the efficiency and effectiveness of fund usage to protect investor interests[128]. Market Expansion and Strategy - The company plans to expand its market presence in Southeast Asia, targeting a market share increase of 10% by the end of 2024[20]. - The company plans to rely on a high-end and diversified product development strategy to continuously launch more competitive products and expand market share for long-term healthy business growth[6]. - The company is exploring opportunities for market expansion and potential mergers and acquisitions to strengthen its competitive position in the industry[140]. - The company is committed to a globalization strategy, actively expanding its overseas market presence and developing more high-quality customers in both domestic and international markets[150]. Product Development and Innovation - The company is developing a new line of high-purity chemicals aimed at the semiconductor industry, with an expected launch in Q3 2024[20]. - The company has established a high-end photoresist production line and testing platform to enhance the "self-controllable" level in the semiconductor materials sector, aiming for domestic substitution of semiconductor materials[60]. - The company has initiated a high-end photoresist R&D project for integrated circuit manufacturing, acquiring ASML1900 Gi and Nikon KrF S207 lithography machines to support the development of ArF and KrF photoresists for 90-28nm chip processes[60]. - The company has developed a new type of KrF photoresist with a high aspect ratio greater than 5:1, aiming to achieve a maximum aspect ratio of 15:1 for applications in SAW/BAW[97]. - The company has completed the development of a new process technology for hydrogen peroxide production, improving safety and reducing production costs[99]. Sustainability and Compliance - The company is committed to sustainability, aiming to reduce its carbon footprint by 15% over the next three years[20]. - The company has received various environmental permits, including a hazardous chemicals operating permit valid until April 2026[71]. - The company is committed to maintaining compliance with safety and environmental regulations, ensuring operational continuity[71]. - The company has established a comprehensive internal control system to mitigate risks and ensure the achievement of operational goals[190]. Financial Management and Investment - The company incurred goodwill impairment of ¥144,429,100 and other asset impairment of ¥24,927,800, totaling a profit reduction of ¥169,356,900[81]. - The company has established dedicated accounts for managing the raised funds, ensuring compliance with regulatory requirements[128]. - The company has not engaged in any significant changes to the investment projects associated with the raised funds[131]. - The company is focused on strategic investments and partnerships to enhance its market position and operational efficiency[199]. Competitive Landscape - The company operates in the electronic materials sector, focusing on semiconductor and new energy applications, with key products including high-purity wet electronic chemicals and photoresists[35]. - The company is positioned in the electronic chemical industry, which is characterized by high technical barriers and significant profit margins despite smaller market spaces for individual products[36]. - The company has a competitive edge in the market due to its unique product performance and high technical barriers, which contribute to its profitability[36]. - The domestic market for lithium battery materials is becoming increasingly competitive, with local manufacturers gradually replacing imported products in the negative electrode binder market, where foreign products previously held over 90% market share[142]. Risks and Challenges - The company faces risks from market demand fluctuations and competition, particularly in the semiconductor and lithium battery sectors, which could impact revenue and profit[160]. - There is a risk of bad debts from accounts receivable, particularly if clients in the semiconductor and LED industries face financial difficulties[164]. - The company is aware of the risks associated with production investment projects and fixed asset depreciation, which could impact profitability[169].

Financial Performance - The company's revenue for Q1 2025 reached ¥369,945,970.05, representing a 12.17% increase compared to ¥329,793,849.99 in the same period last year[6] - Net profit attributable to shareholders was ¥43,502,632.69, a significant increase of 582.15% from a loss of ¥9,022,578.96 in the previous year[6] - Basic earnings per share improved to ¥0.04, compared to a loss of ¥0.01 per share in the same quarter last year, marking a 500.00% increase[6] - Total profit for the period was ¥57,734,282.31, up 545.08% from a loss of ¥12,971,629.14 in the previous year[13] - Net profit for the period reached ¥52,878,860.27, compared to a net loss of ¥13,371,083.94 in the previous period, indicating a significant turnaround[30] Cash Flow - The net cash flow from operating activities was ¥61,432,656.12, up 94.80% from ¥31,535,842.78 in Q1 2024[15] - The company reported a significant increase in cash flow from investment activities, with cash inflow totaling ¥557,047,743.71, a 1128.96% increase from ¥45,326,799.86 in Q1 2024[15] - Cash received from sales of goods and services was ¥302,539,531.07, an increase from ¥289,181,187.17 in the previous period[32] - Total cash outflow from operating activities was ¥255,660,759.41, down from ¥271,277,960.11 in the previous period[32] - Cash inflow from financing activities was ¥90,474,522.30, a decrease from ¥525,664,257.69 in the previous period[33] Assets and Liabilities - Total assets at the end of Q1 2025 were ¥5,239,211,521.11, a 1.73% increase from ¥5,149,971,379.79 at the end of the previous year[6] - Total liabilities increased to ¥1,550,526,865.07 from ¥1,520,873,038.92, which is a rise of about 2%[27] - The equity attributable to shareholders of the parent company rose to ¥2,559,369,001.14 from ¥2,513,128,723.68, showing an increase of approximately 1.8%[27] Investment and Shareholder Information - Investment income surged to ¥13,503,444.06, a 3246.68% increase from a loss of ¥429,133.62 in Q1 2024[13] - The largest shareholder, New Silver International Limited, holds 15.59% of shares, totaling 165,176,124 shares[17] - Total number of common shareholders at the end of the reporting period is 81,630[17] - The top ten shareholders hold a significant portion of shares, with the top five alone accounting for over 26%[17] - The company has a total of 62,001,468 restricted shares at the end of the reporting period[21] Operational Costs and Expenses - Total operating costs rose to ¥354,522,264.64 from ¥335,739,038.81, reflecting an increase of about 5.2% year-over-year[29] - Research and development expenses decreased to ¥19,245,271.41 from ¥23,536,185.62, a reduction of about 18.4% year-over-year[30] Future Plans and Strategies - The company plans to issue shares for asset acquisition and related party transactions, as approved in board meetings on March 30, 2025[22] - The company’s financial strategy includes potential market expansion and new product development as indicated in the recent board meetings[22] - The company plans to expand its market presence and invest in new technologies to drive future growth[30] Other Financial Metrics - The weighted average return on equity rose to 1.72%, compared to -0.40% in the same period last year, reflecting a 2.12% improvement[6] - Total comprehensive income amounted to ¥52,155,432.80, a decrease of ¥13,762,957.54 compared to the previous period[31] - Cash and cash equivalents at the end of the period totaled ¥493,453,178.69, down from ¥1,837,872,478.73 in the previous period[33] - The company did not undergo an audit for the first quarter report[34]

| 证券代码：300655 | 证券简称：晶瑞电材 | 公告编号：2025-036 | | --- | --- | --- | | 债券代码：123031 | 债券简称：晶瑞转债 | | | 债券代码：123124 | 债券简称：晶瑞转 2 | | 晶瑞电子材料股份有限公司 关于召开 2025 年第三次临时股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 根据晶瑞电子材料股份有限公司（以下简称"公司"）第四届董事会第四次会议 决议，公司决定于 2025 年 4 月 25 日召开 2025 年第三次临时股东大会。现将有关事 项通知如下： 一、召开会议的基本情况 1、股东大会届次：2025 年第三次临时股东大会 2、股东大会的召集人：董事会。公司于 2025 年 4 月 9 日召开了第四届董事会 第四次会议，审议通过了《关于召开 2025 年第三次临时股东大会的议案》。 3、会议召开的合法性、合规性：本次股东大会的召开符合《中华人民共和国 公司法》、《深圳证券交易所创业板股票上市规则》和《公司章程》等有关规定。 4、会议召开的时间： （1）现场会议召 ...

| | | 晶瑞电子材料股份有限公司（以下简称"公司"）第四届董事会第四次会议 于 2025 年 4 月 9 日以通讯方式及现场会议相结合的方式在公司会议室召开。本 次董事会会议经全体董事一致同意豁免会议通知期限要求，会议已于 2025 年 4 月 8 日以电话及电子邮件等方式发出通知。会议由公司董事长李勍先生召集并主 持，会议应出席董事 9 人，实际出席董事 9 人。公司监事、高级管理人员列席了 会议。本次会议的召集、召开符合有关法律、法规和《公司章程》的规定。 二、董事会会议审议情况 债券代码：123031 债券简称：晶瑞转债 债券代码：123124 债券简称：晶瑞转 2 1、审议通过了《关于召开 2025 年第三次临时股东大会的议案》 晶瑞电子材料股份有限公司 第四届董事会第四次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 特此公告。 1 晶瑞电子材料股份有限公司 董事会 2025 年 4 月 9 日 2 董事会拟定于 2025 年 4 月 25 日下午 14:30 在公司会议室召开 2025 年第三 次临时股东大 ...

| | | 债券代码：123031 债券简称：晶瑞转债 债券代码：123124 债券简称：晶瑞转2 晶瑞电子材料股份有限公司 2025 年第一季度可转换公司债券转股情况公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 1、"晶瑞转债"（债券代码：123031）转股期为2020年3月5日至2025年8月28 日；最新有效的转股价格为3.83元/股。 2、"晶瑞转2"（债券代码：123124）转股期为2022年2月21日至2027年8月15 日；最新有效的转股价格为16.74元/股。 3、2025年第一季度，共有230张"晶瑞转债"完成转股（票面金额共计23,000 元人民币），共计转成6,004股"晶瑞电材"股票（股票代码：300655）；共有13张 "晶瑞转2"完成转股（票面金额共计1,300元人民币），共计转成76股"晶瑞电材" 股票（股票代码：300655）。 4、截至2025年第一季度末，公司剩余"晶瑞转债"票面总金额为52,602,700元 人民币；公司剩余"晶瑞转2"票面总金额为522,602,100元人民币。 根据《深圳证券交易所创 ...

为避免因参与人员泄露本次交易有关信息而对本次交易产生不利影响，公司 和相关中介机构对本次交易事宜采取了严格的保密措施及保密制度。具体情况如 下： 1、公司高度重视保密问题，自各方进行初步磋商时，立即采取了必要的保 密措施。 2、本次交易的证券服务中介机构与公司签订了保密协议，公司与交易对方 在签订的交易协议中约定了相应的保密条款，明确了各方的保密责任与义务并限 定了本次交易相关敏感信息的知悉范围。 3、公司严格按照《上市公司重大资产重组管理办法》《上市公司信息披露管 理办法》等法律、法规及规范性文件的要求，遵循公司章程及内部管理制度的规 定，就本次交易采取了充分必要的保护措施，制定了严格有效的保密制度。 4、公司严格按照《上市公司监管指引第 5 号——上市公司内幕信息知情人 登记管理制度》等相关规定，登记内幕信息知情人信息，并依据本次交易的实际 进展，制作内幕信息知情人登记表及重大事项进程备忘录。 晶瑞电子材料股份有限公司董事会 关于本次交易采取的保密措施及保密制度的说明 晶瑞电子材料股份有限公司（以下简称"公司"）拟发行股份购买湖北长江（潜 江）产业投资基金合伙企业（有限合伙）、国家集成电路产业投资基金二期 ...

关于发行股份购买资产暨关联交易 报告书（草案）与预案差异对比说明 晶瑞电子材料股份有限公司（以下简称"上市公司"）拟发行股份购买湖北长 江（潜江）产业投资基金合伙企业（有限合伙）、国家集成电路产业投资基金二期 股份有限公司、厦门闽西南弘盛科创基金合伙企业（有限合伙）、深圳市国信亿合 新兴产业私募股权投资基金合伙企业（有限合伙）共4名交易对方合计持有的晶瑞 （湖北）微电子材料有限公司76.0951%股权（以下简称"本次交易"）。 2024年11月18日，公司披露了《晶瑞电子材料股份有限公司发行股份购买资产 暨关联交易预案》（以下简称"重组预案"）及相关公告。 2025年3月30日，公司召开第四届董事会第三次会议审议通过了《关于<晶瑞 电子材料股份有限公司发行股份购买资产暨关联交易报告书（草案）>及其摘要的 议案》等相关议案，现就《晶瑞电子材料股份有限公司发行股份购买资产暨关联交 易报告书（草案）》（以下简称"重组报告书"）与重组预案内容的主要差异情况说 明如下： 晶瑞电子材料股份有限公司 | 重组报告书章节 | 重组预案章节 | 与重组预案差异情况说明 1、删除"审计、评估工作尚未完成的风险"、"交易 | | ...

目 录 | 一、审计报告…………………………………………………………第 | 1—4 | 页 | | --- | --- | --- | | 二、财务报表…………………………………………………………第 | 5—9 | 页 | | （一）资产负债表………………………………………………… | 第 | 5 页 | | --- | --- | --- | | （二）利润表……………………………………………………… | 第 | 6 页 | | （三）现金流量表………………………………………………… | 第 | 7 页 | | （四）所有者权益变动表………………………………………第 | 8—9 | 页 | | | | | | | 审 计 报 告 天健审〔2025〕1029 号 晶瑞（湖北）微电子材料有限公司全体股东： 一、审计意见 我们审计了晶瑞（湖北）微电子材料有限公司（以下简称湖北晶瑞公司）财 务报表，包括 2022 年 12 月 31 日、2023 年 12 月 31 日、2024 年 10 月 31 日的资 产负债表，2022 年度、2023 年度、2024 年 1-10 月的利润表、现金流量表、所 有者权益变动表 ...

晶瑞电子材料股份有限公司董事会 关于本次交易摊薄即期回报情况及填补措施的说明 晶瑞电子材料股份有限公司（以下简称公司或"上市公司"）拟发行股份购买 湖北长江（潜江）产业投资基金合伙企业（有限合伙）、国家集成电路产业投资 基金二期股份有限公司、厦门闽西南弘盛科创基金合伙企业（有限合伙）、深圳 市国信亿合新兴产业私募股权投资基金合伙企业（有限合伙）共 4 名交易对方合 计持有的晶瑞（湖北）微电子材料有限公司 76.0951%股权（以下简称"本次交 易"）。 根据《国务院办公厅关于进一步加强资本市场中小投资者合法权益保护工 作的意见》（国办发[2013]110号）、《国务院关于进一步促进资本市场健康发 展的若干意见》（国发[2014]17号）和《关于首发及再融资、重大资产重组摊薄 即期回报有关事项的指导意见》（证监会公告[2015]31号）等相关规定的要求， 为保障中小投资者知情权，维护中小投资者利益，公司就本次交易对即期回报 摊薄的影响进行了认真分析，提出了具体的填补回报措施，具体内容如下： 根据天健会计师出具的审计报告和备考审阅报告，公司本次交易前后主要财 务指标如下： | 项目 | | 2024年1-10月/ ...

长城证券股份有限公司 关于晶瑞电子材料股份有限公司 内幕信息知情人登记制度的制定和执行情况 的核查意见 晶瑞电子材料股份有限公司（以下简称"晶瑞电材"、"公司"或"上市公司"） 拟向湖北长江（潜江）产业投资基金合伙企业（有限合伙）、国家集成电路产业 投资基金二期股份有限公司、厦门闽西南弘盛科创基金合伙企业（有限合伙）、 深圳市国信亿合新兴产业私募股权投资基金合伙企业（有限合伙）发行股份购买 其持有的晶瑞（湖北）微电子材料有限公司 76.0951%股权（以下简称"本次交 易"）。长城证券股份有限公司（以下简称"长城证券"或"独立财务顾问"）作 为晶瑞电材本次交易的独立财务顾问，对晶瑞电材内幕信息知情人登记管理制度 的制定和执行情况进行了核查，具体如下： 一、上市公司内幕信息知情人登记管理制度的制定和执行情况 （一）上市公司内幕信息知情人登记制度制定情况 2020 年 8 月，上市公司根据《中华人民共和国公司法》、《中华人民共和国 证券法》、《上市公司信息披露管理办法》、《深圳证券交易所股票上市规则》等法 律、法规、规章、规范性文件以及《苏州晶瑞化学股份有限公司章程》（以下简 称"《公司章程》"）、《苏州晶瑞化学 ...